Organogenesis Holdings (ORGO) Total Current Liabilities (2015 - 2026)

Organogenesis Holdings' Total Current Liabilities history runs 12 years deep, the most recent figure standing at $76.0 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 16.86% year-over-year to $76.0 million; the TTM figure through Mar 2026 stood at $76.0 million (up 16.86% YoY), while the FY2025 annual figure was $100.1 million, up 29.23% from the prior year.
• Total Current Liabilities was $76.0 million for Q1 2026 at Organogenesis Holdings, down from $100.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $100.1 million in Q4 2025 to a low of $65.1 million in Q1 2025.
• Historically, Total Current Liabilities has averaged $80.2 million across 5 years, with a median of $78.5 million in 2022.
• Biggest YoY gain for Total Current Liabilities was 29.23% in 2025; the steepest drop was 23.2% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $75.0 million in 2022, then grew by 7.31% to $80.5 million in 2023, then dropped by 3.77% to $77.5 million in 2024, then advanced by 29.23% to $100.1 million in 2025, then fell by 24.07% to $76.0 million in 2026.
• The last three Total Current Liabilities figures came in at $76.0 million (Q1 2026), $100.1 million (Q4 2025), and $90.3 million (Q3 2025), per Business Quant data.